Page last updated: 2024-11-01

nisoldipine and Hypertension, Renovascular

nisoldipine has been researched along with Hypertension, Renovascular in 5 studies

Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.

Hypertension, Renovascular: Hypertension due to RENAL ARTERY OBSTRUCTION or compression.

Research Excerpts

ExcerptRelevanceReference
"In patients with chronic renal failure, decrement in BP was 25/16 mmHg (systolic and diastolic BP, respectively)."6.65[Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension]. ( Breuer, G; Kaufmann, W; Wambach, G, 1984)
"In patients with chronic renal failure, decrement in BP was 25/16 mmHg (systolic and diastolic BP, respectively)."2.65[Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension]. ( Breuer, G; Kaufmann, W; Wambach, G, 1984)
"Nisoldipine treatment for five months prevented a rise in blood pressure in Cohen diabetic rats with Goldblatt hypertension, compared to a significant elevation in untreated controls."1.29Effects of nisoldipine on hypertension and glomerulosclerosis in Cohen diabetic rat with Goldblatt hypertension. ( Cohen, AM; Rosenmann, E; Rosenthal, T, 1993)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wambach, G1
Breuer, G1
Kaufmann, W1
Kazda, S1
Garthoff, B1
Meyer, H1
Schlossmann, K1
Stoepel, K1
Towart, R1
Vater, W1
Wehinger, E1
Rosenthal, T3
Grossman, E2
Rosenmann, E1
Cohen, AM1

Trials

1 trial available for nisoldipine and Hypertension, Renovascular

ArticleYear
[Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension].
    Arzneimittel-Forschung, 1984, Volume: 34, Issue:5

    Topics: Adult; Aged; Aldosterone; Calcium Channel Blockers; Electrolytes; Female; Heart Rate; Humans; Hydroc

1984

Other Studies

4 other studies available for nisoldipine and Hypertension, Renovascular

ArticleYear
Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552).
    Arzneimittel-Forschung, 1980, Volume: 30, Issue:12

    Topics: Animals; Blood Coagulation; Calcium; Cats; Chemical Phenomena; Chemistry; Diuresis; Dogs; Female; Gu

1980
Nisoldipine for hypertension.
    Israel journal of medical sciences, 1994, Volume: 30, Issue:11

    Topics: Animals; Disease Models, Animal; Humans; Hypertension; Hypertension, Renovascular; Nisoldipine; Rats

1994
Effects of nisoldipine on hypertension and glomerulosclerosis in Cohen diabetic rat with Goldblatt hypertension.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1993, Volume: 15, Issue:2

    Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Diabetic

1993
The hypotensive effect of nisoldipine in renovascular hypertensive rats.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1986, Volume: 4, Issue:5

    Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Hypertension, Renovascular; Nifedipine;

1986